EDRS
NVO

Edmond de Rothschild (Suisse)’s Novo Nordisk NVO Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$104K Hold
5,000
– – 0.03% 256
2016
Q2 		$134K Buy
+5,000
New +$137K 0.04% 211

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s NVO Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) held its Novo Nordisk (NVO) position steady in Q3 2016 at 5,000 shares worth $104K. The position accounts for 0.03% of the portfolio, ranked #256.

Edmond de Rothschild (Suisse) first reported a position in NVO in Q2 2016 and has held it in 2 quarters since. The position peaked at $134K in Q2 2016. 513 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

  • Edmond de Rothschild (Suisse) held 5,000 shares of Novo Nordisk worth $104K as of Q3 2016.
  • Edmond de Rothschild (Suisse) left its Novo Nordisk share count unchanged in Q3 2016.
  • Novo Nordisk made up 0.03% of Edmond de Rothschild (Suisse)'s portfolio in Q3 2016, its #256 holding.
  • Edmond de Rothschild (Suisse) first reported a position in Novo Nordisk in Q2 2016 and has held it in 2 quarters since.
  • Edmond de Rothschild (Suisse)'s Novo Nordisk position peaked at $134K in Q2 2016.
  • 513 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.